Effect of monocrotophos, an organophosphorus insecticide, on the striatal dopaminergic system in a mouse model of Parkinson's disease

被引:10
|
作者
Ali, Shaheen Jafri [1 ]
Rajini, Padmanabhan Sharda [1 ]
机构
[1] Cent Food Technol Res Inst, CSIR, Dept Food Protectants & Infestat Control, Mysore 570020, Karnataka, India
关键词
Dopamine; mice; monocrotophos; oxidative stress; Parkinson's disease; striatum; tyrosine hydroxylase; ACUTE CHLORPYRIFOS EXPOSURE; INDUCED OXIDATIVE STRESS; ALPHA-SYNUCLEIN; TIME-COURSE; VITAMIN-C; PESTICIDES; ACETYLCHOLINESTERASE; MPTP; DAMAGE; BRAIN;
D O I
10.1177/0748233714547733
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our earlier study had shown that low concentrations of monocrotophos (MCP) elicited dopaminergic features of Parkinson's disease (PD) in the nematode Caenorhabditis elegans. In the present study, the effect of low doses of MCP on the striatal dopaminergic neurons was investigated using the mouse model system. MCP was initially screened for its ability to cause any neurobehavioral deficits and alterations in the dopaminergic system in Swiss albino mice, aged 8 weeks and weighing 25-30 g, with repeated doses at 0.3 and 0.6 mg/kg body weight (b.w.)/day for 7 days and 30 days. Mice were treated with four intraperitoneal injections for every 2 h with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at the dosage of 14 mg/kg b.w. MCP was administered to these mice at the above-mentioned doses for 7 days. Mice administered with MCP alone revealed a significant < 0.05) reduction in the dopamine (DA) content at both 7 and 30 days and showed a significant (p < 0.05) increase in neurobehavioral deficits. Interestingly, when MCP was administered for 7 days to MPTP-treated mice, further significant decrease in both DA content and increase in neurobehavioral deficits were apparent. The extent of reactive oxygen species and lipid peroxidation were markedly increased, while the ratio of reduced to oxidized glutathione levels were significantly decreased (p < 0.05) in the treated mice as compared to the control. Significant histopathological alterations and a marked reduction in the number of tyrosine hydroxylase positive cells were evident in striatum of mice treated with higher doses of MCP. These changes were comparable to that seen in mice treated with MPTP and post-administered lower doses of MCP. Our findings suggest that MCP per se has the propensity to induce pathological changes in the dopaminergic neurons as well as augment the degeneration in a compromised nigrostriatal system such as that in PD.
引用
收藏
页码:1153 / 1165
页数:13
相关论文
共 50 条
  • [41] Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson's disease
    Yao, Ning
    Wu, Yanhong
    Zhou, Yan
    Ju, Lili
    Liu, Yujun
    Ju, Rongkai
    Duan, Deyi
    Xu, Qunyuan
    BRAIN RESEARCH, 2015, 1625 : 255 - 274
  • [42] 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease
    Shi, Limin
    Jia, Lu
    Wang, Yiyun
    Xiu, Minxia
    Xie, Junxia
    NEUROCHEMICAL RESEARCH, 2023, 48 (06) : 1707 - 1715
  • [43] Functionalized composite scaffolds improve the engraftment of transplanted dopaminergic progenitors in a mouse model of Parkinson's disease
    Wang, Ting-Yi
    Bruggeman, Kiara F.
    Kauhausen, Jessica A.
    Rodriguez, Alexandra L.
    Nisbet, David R.
    Parish, Clare L.
    BIOMATERIALS, 2016, 74 : 89 - 98
  • [44] 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson’s Disease
    Limin Shi
    Lu Jia
    Yiyun Wang
    Minxia Xiu
    Junxia Xie
    Neurochemical Research, 2023, 48 : 1707 - 1715
  • [45] Predicting Neuropsychiatric Symptoms of Parkinson's Disease with Mea-sures of Striatal Dopaminergic Deficiency
    Bishnoi, Ram
    Badir, Marina C.
    Surya, Sandarsh
    Youssef, Nagy A.
    CURRENT ALZHEIMER RESEARCH, 2021, 18 (06) : 499 - 504
  • [46] Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease
    Zheng, Meizhu
    Liu, Chunming
    Fan, Yajun
    Yan, Pan
    Shi, Dongfang
    Zhang, Yuchi
    NEUROPHARMACOLOGY, 2017, 116 : 412 - 420
  • [47] Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease
    Tate, Ciara C.
    Chou, Vivian P.
    Campos, Carla
    Moalem, Alimohammed S.
    Di Monte, Donato A.
    McGrogan, Michael
    Case, Casey C.
    Manning-Bog, Amy B.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2017, 11 (06) : 1835 - 1843
  • [48] Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease
    Parkhe, Abhijeet
    Parekh, Pathik
    Nalla, Lakshmi Vineela
    Sharma, Nishant
    Sharma, Monika
    Gadepalli, Anagha
    Kate, Abhijeet
    Khairnar, Amit
    NEUROSCIENCE LETTERS, 2020, 716
  • [49] No effect of Parkinson's disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects
    Pak, Kyoungjune
    Lee, Myung Jun
    Kim, Keunyoung
    Kim, In Joo
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (11) : 1187 - 1192
  • [50] Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease
    Kuroiwa, Hayato
    Yokoyama, Hironori
    Kimoto, Hiroki
    Kato, Hiroyuki
    Araki, Tsutomu
    METABOLIC BRAIN DISEASE, 2010, 25 (02) : 177 - 183